Skip to content
value.today

USGI Medical Inc.

Total raised
$34 M
3 rounds on record
Latest round
$2 M
Feb 2019
First round on record
May 2012
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of USGI Medical Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2019$2 MNo. 3$2 to $10 million

USGI Medical Inc.: Raise no. 3, Feb 2019

Investors in this round

1 investor had bought by the notice of Jun 10, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Carlos Babini · Executive Officer, Director
  • George Abi-Chahine · Director
  • Guy Nohra · Director
  • Scott Moonly · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Carlos Babini, Pres. and CEO. Source: SEC Form D and 1 amendment, newest notice filed Jun 10, 2019. Read the notice at the SEC.

debt, optionsSEC
Nov 2014$15 MNo. 2$10 to $50 million

USGI Medical Inc.: Raise no. 2, Nov 2014

Investors in this round

2 investors had bought by the notice of Jan 27, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Offering of Series 3 Preferred Stock and the underlying shares of Common Stock issuable upon conversion of the Series E Preferred Stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Cox · Executive Officer
  • Scott Moonly · Executive Officer, Director
  • Tracy Maahs · Executive Officer
  • George Abi-Chahine · Director
  • Guy Nohra · Director
  • Mike Chuisano · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Scott Moonly, President, CEO, CFO and Secretary. Source: SEC Form D, newest notice filed Jan 27, 2015. Read the notice at the SEC.

equitySEC
May 2012$17 MNo. 1$10 to $50 million

USGI Medical Inc.: Raise no. 1, May 2012

Investors in this round

8 investors had bought by the notice of May 23, 2012: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: "Offering of Series 1 Preferred Stock (""Series 1""), warrants to purchase Series 1 (the ""Warrants""), the underlying shares of Series 1 issuable upon exercise of Warrants and the underlying shares o
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Cox · Executive Officer
  • Scott Moonly · Executive Officer, Director
  • Tracy Maahs · Executive Officer
  • George Abi-Chahine · Director
  • Guy Nohra · Director
  • William Mavity · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Item 13(b) includes conversion of $5,162,212.18 of principal & interest of convertible notes into shares of Series 1, converting at a 25% discount. Item 13(a) doesn't include $2,143,628.50 that may be sold pursuant to the exercise of outstanding warrants.”

Signed by Scott Moonly, President, CEO, CFO and Secretary. Source: SEC Form D, newest notice filed May 23, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • USGI Medical Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2019).

    SEC Form D · Jun 2019

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2019

That is all the official record says: USGI Medical Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of USGI Medical Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 8 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by USGI Medical Inc.
NameRoleNamed in
Carlos BabiniExecutive officerJun 2019
John CoxExecutive officerJan 2015
Scott MoonlyExecutive officerJan 2015
Tracy MaahsExecutive officerJan 2015
Carlos BabiniDirectorJun 2019
George Abi-ChahineDirectorJun 2019
Guy NohraDirectorJun 2019
Scott MoonlyDirectorJun 2019
Mike ChuisanoDirectorJan 2015
William MavityDirectorMay 2012